Bausch Health Companies Stock Filter Stocks by Fundamentals
| BHC Stock | USD 8.63 0.13 1.48% |
Bausch Health Companies fundamentals help investors to digest information that contributes to Bausch Health's financial success or failures. It also enables traders to predict the movement of Bausch Stock. The fundamental analysis module provides a way to measure Bausch Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bausch Health stock.
Bausch | Shares Owned by Institutions |
Bausch Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Bausch Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Bausch Health's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Bausch Health Institutional Holders
Institutional Holdings refers to the ownership stake in Bausch Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bausch Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bausch Health's value.| Shares | Mizuho Markets Americas Llc | 2023-12-31 | 7 M | Citadel Advisors Llc | 2023-09-30 | 6.1 M | Mfn Partners Management, Lp | 2023-12-31 | 6 M | Kohlberg Kravis Roberts & Co Lp | 2023-12-31 | 5.2 M | Norges Bank | 2023-12-31 | 3.9 M | Natixis Sa | 2023-12-31 | 3.2 M | Bank Of Montreal | 2023-12-31 | 3 M | Bmo Capital Markets Corp. | 2023-12-31 | 3 M | Bnp Paribas Arbitrage, Sa | 2023-12-31 | 3 M | Icahn Carl C | 2023-12-31 | 34.7 M | Goldentree Asset Management Lp | 2023-12-31 | 27.6 M |
Bausch Fundamentals
| Return On Equity | -6.87 | ||||
| Return On Asset | 0.0382 | ||||
| Profit Margin | (0.07) % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 25.79 B | ||||
| Shares Outstanding | 366.67 M | ||||
| Shares Owned By Insiders | 8.04 % | ||||
| Shares Owned By Institutions | 79.60 % | ||||
| Number Of Shares Shorted | 22.5 M | ||||
| Price To Earning | 9.26 X | ||||
| Price To Book | 18.78 X | ||||
| Price To Sales | 0.37 X | ||||
| Revenue | 8.76 B | ||||
| Gross Profit | 5.76 B | ||||
| EBITDA | 2.89 B | ||||
| Net Income | (611 M) | ||||
| Cash And Equivalents | 564 M | ||||
| Cash Per Share | 1.34 X | ||||
| Total Debt | 22.39 B | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | (2.80) X | ||||
| Cash Flow From Operations | 1.03 B | ||||
| Short Ratio | 9.91 X | ||||
| Earnings Per Share | (1.62) X | ||||
| Price To Earnings To Growth | 0.63 X | ||||
| Target Price | 10.33 | ||||
| Number Of Employees | 20.27 K | ||||
| Beta | 0.86 | ||||
| Market Capitalization | 3.23 B | ||||
| Total Asset | 27.35 B | ||||
| Retained Earnings | (9.78 B) | ||||
| Working Capital | 1.29 B | ||||
| Current Asset | 984.02 M | ||||
| Current Liabilities | 730.59 M | ||||
| Net Asset | 27.35 B |
About Bausch Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bausch Health Companies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bausch Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bausch Health Companies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bausch Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bausch Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will appreciate offsetting losses from the drop in the long position's value.Moving together with Bausch Stock
| 0.77 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
| 0.8 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
Moving against Bausch Stock
| 0.75 | BNR | Burning Rock BiotechLtd Financial Report 4th of June 2024 | PairCorr |
| 0.61 | NVS | Novartis AG ADR Earnings Call Next Week | PairCorr |
| 0.53 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.45 | DNA | Ginkgo Bioworks Holdings Financial Report 8th of May 2024 | PairCorr |
| 0.44 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to Bausch Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bausch Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bausch Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bausch Health Companies to buy it.
The correlation of Bausch Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bausch Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bausch Health Companies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bausch Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bausch Health Piotroski F Score and Bausch Health Altman Z Score analysis. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.115 | Earnings Share (1.62) | Revenue Per Share 23.998 | Quarterly Revenue Growth 0.098 | Return On Assets 0.0382 |
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.